Amarin Corporation plc (AMRN)
Largest Insider Buys in Sector
AMRN Stock Price History Chart
AMRN Stock Performance
About Amarin Corporation plc
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with …
Insider Activity of Amarin Corporation plc
Over the last 12 months, insiders at Amarin Corporation plc have bought $118,124 and sold $26,963 worth of Amarin Corporation plc stock.
On average, over the past 5 years, insiders at Amarin Corporation plc have bought $218,417 and sold $21.86M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Berg Aaron (President and CEO) — $102,400. Holt Patrick (President and CEO) — $15,724.
The last purchase of 160,000 shares for transaction amount of $102,400 was made by Berg Aaron (President and CEO) on 2024‑08‑02.
List of Insider Buy and Sell Transactions, Amarin Corporation plc
| 2024-08-02 | President and CEO | 160,000 0.0389% | $0.64 | $102,400 | -5.77% | |||
| 2024-01-22 | President and CEO | 14,426 0.0033% | $1.09 | $15,724 | -26.73% | |||
| 2023-12-12 | Sale | Chief Scientific Officer | 34,131 0.0084% | $0.79 | $26,963 | +10.22% | ||
| 2023-08-16 | President and CEO | 300,000 0.0723% | $1.04 | $312,315 | -17.88% | |||
| 2022-06-13 | 55,000 0.0137% | $1.69 | $92,730 | -21.76% | ||||
| 2021-12-15 | director | 2,000 0.0005% | $3.15 | $6,310 | -52.31% | |||
| 2021-12-14 | director | 10,000 0.0025% | $3.27 | $32,689 | -52.00% | |||
| 2021-08-12 | Sale | SVP and CFO | 120,000 0.0282% | $5.25 | $630,240 | -41.05% | ||
| 2021-06-04 | director | 10,000 0.0026% | $4.54 | $45,350 | -17.42% | |||
| 2021-06-03 | director | 5,000 0.0013% | $4.62 | $23,115 | -19.61% | |||
| 2021-02-01 | Sale | Chief Scientific Officer | 435,456 0.11% | $8.06 | $3.51M | -39.85% | ||
| 2021-01-27 | Sale | Chief Scientific Officer | 843,258 0.2332% | $8.01 | $6.76M | -33.52% | ||
| 2020-11-30 | director | 50,000 0.0125% | $4.86 | $243,035 | +1.61% | |||
| 2020-11-11 | Sale | President and CEO | 827,130 0.2094% | $4.07 | $3.36M | +22.63% | ||
| 2020-11-10 | Sale | President and CEO | 307,680 0.0792% | $4.13 | $1.27M | +22.63% | ||
| 2020-03-04 | Sale | President and CEO | 400,000 0.1106% | $15.99 | $6.4M | -58.77% | ||
| 2020-01-03 | Sale | director | 600,000 0.0965% | $12.17 | $7.3M | -67.88% | ||
| 2019-12-16 | Sale | CHIEF COMMERCIAL OFFICER | 86,506 0.02% | $19.03 | $1.65M | -70.15% | ||
| 2019-12-16 | Sale | director | 200,000 0.0424% | $17.42 | $3.48M | -70.15% | ||
| 2019-12-16 | Sale | SVP and CFO | 50,000 0.0142% | $23.36 | $1.17M | -70.15% |
Insider Historical Profitability
| Berg Aaron | President and CEO | 805380 0.1958% | $0.59 | 1 | 4 | |
| Holt Patrick | President and CEO | 314426 0.0765% | $0.59 | 2 | 0 | |
| THERO JOHN F | President and CEO | 2739000 0.666% | $0.59 | 6 | 9 | +54.85% |
| Zakrzewski Joseph S | director | 196547 0.0478% | $0.59 | 3 | 16 | <0.0001% |
| WOLD OLSEN PER | 149000 0.0362% | $0.59 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Sarissa Capital Management LP | $22.14M | 6.05 | 24.85M | 0% | +$0 | 3.87 | |
| Kynam Capital Management Lp | $10.71M | 2.93 | 12.02M | 0% | +$0 | 0.14 | |
| DG Capital | $5.74M | 1.57 | 6.44M | +19.23% | +$925,812.88 | 3.72 | |
| Eversept Partners LP | $5.53M | 1.51 | 6.21M | +1.92% | +$104,440.07 | 0.43 | |
| Morgan Stanley | $3.22M | 0.88 | 3.61M | -35.1% | -$1.74M | <0.0001 |